Fish contains essential polyunsaturated fatty acids (n-3 PUFA) which increase n-3 PUFA concentrations in the cardiac membrane and influence cardio electrophysiology, which might have antiarrhythmic effects and so lower risk of fatal CHD. (1, 2) Clinical trials of n-3 PUFA supplements conducted in high risk populations show no significant benefit, (3) results from observational studies on fish intake show heterogeneous results. (4) N-3 PUFA containing supplements, mainly cod liver oil, are widely used in the UK and by 24 % in the Norfolk-based European Prospective Investigation into Cancer (EPIC-Norfolk). (5, 6) We studied the association between n-3 PUFA Total Nutrient Intake (TNI, i.e. intake from foods and supplements), n-3 PUFA supplement use and fatal CHD in a general population-based cohort.

